Acelot, Inc. is a clinical-stage biopharmaceutical company headquartered in South San Francisco, California, developing first-in-class small-molecule therapies for neurodegenerative diseases with high unmet need. Its lead candidate, ACE-2223, is designed to target misfolded and aggregated TDP-43 and restore the protein's healthy form and function, addressing pathology central to amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration (FTLD). Acelot's discovery work is powered by Resolute, an internal integrated drug-discovery platform combining AI-driven computational chemistry with structural and biological insight to drug historically intractable protein targets. Acelot publishes no public API, developer portal, SDK or machine-readable specification; its four public GitHub repositories are forks of third-party cheminformatics tooling.
Acelot is profiled on the APIs.io network. Tagged areas include Company, Biotechnology, Pharmaceuticals, Drug Discovery, and Life Sciences.
Acelot’s developer surface includes engineering blog and 8 more developer resources.
Regulatory Posture applies to this provider. Its tags matched the
Health regime, so
Regulatory Posture carries 15 points of the composite.
If this regime is wrong for your business, say so on your
provider repo — the
applicability map is public and we will correct it.
Create-or-Update Ergonomics could not be measured. We hold no machine-readable contract for
this provider to read, so there is nothing to measure a write surface against. Excluded rather than scored zero:
never-measured and measured-empty are different facts. Publishing an OpenAPI is what makes this facet — and
several others — scorable at all.
The six quality facets above are damped to 85 points between them,
because the conditional facet above carries the other
15. That is why each facet's contribution is shown against a damped
maximum: raising a quality facet moves the composite by 85% of its nominal
weight, not 100%. The full arithmetic is at apis.io/rating/.
Show this score on your site.
It updates itself when the score changes. Paste this where you link to your API docs:
<a href="https://apis.io/providers/acelot-inc/"><img src="https://apis.io/badge/acelot-inc/card.svg" alt="Acelot on APIs.io — Kin Score by API Evangelist"></a>
Other styles, a README pill and a shields.io endpoint are on the badge page.
Raise your score.
Agent readiness — checks not met, largest first (exact, from this profile):
Machine-Readable Auth+10 pts — a served openid-configuration/oauth-authorization-server carrying `issuer` (served), else the securitySchemes class in the provider OpenAPIs — bound (mutualTLS, DPoP, Signature) > negotiable (oauth2 authorizationCode/clientCredentials, openIdConnect) > bearer (http bearer, apiKey)
Idempotency+9 pts — OpenAPI mutating operations declare an idempotency key — a header, a request-body property, or a named de-duplication token whose own description says so (verified); else common[].type matches /idempoten/i (documented)
Stable Error Semantics+8 pts — OpenAPI $refs a shared error schema across 4xx/5xx responses (verified), else common[].type includes ErrorCatalog / ErrorCodes / DeclineCodes
13 more unmet checks in the Agent Readiness table above.
Kin Score — facets with the most composite points still available (weight × headroom):
aid: acelot-inc
name: Acelot
description: Acelot, Inc. is a clinical-stage biopharmaceutical company headquartered in South San Francisco, California,
developing first-in-class small-molecule therapies for neurodegenerative diseases with high unmet need. Its lead candidate,
ACE-2223, is designed to target misfolded and aggregated TDP-43 and restore the protein's healthy form and function, addressing
pathology central to amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration (FTLD). Acelot's discovery
work is powered by Resolute, an internal integrated drug-discovery platform combining AI-driven computational chemistry
with structural and biological insight to drug historically intractable protein targets. Acelot publishes no public API,
developer portal, SDK or machine-readable specification; its four public GitHub repositories are forks of third-party cheminformatics
tooling.
accessModel:
pricing: unknown
onboarding: unknown
trial: false
try_now: false
public: false
label: Unknown
confidence: low
probe_state: none
source:
- security
generated: '2026-11-06'
method: derived
image: https://static1.squarespace.com/static/6721bd430e24a6572ea4152a/t/6732691e70799e3f6a4e8b71/1731356958733/Acelot-Website-LogoKnockout-111124-v01.png?format=1500w
url: https://raw.githubusercontent.com/api-evangelist/acelot-inc/refs/heads/main/apis.yml
x-type: company
x-source: harvest:secondary-market
x-tier: stub
x-tier-reason: harvest
specificationVersion: '0.20'
created: '2026-09-06'
modified: '2026-09-06'
tags:
- Company
- Biotechnology
- Pharmaceuticals
- Drug Discovery
- Life Sciences
- Neurodegenerative Disease
- Artificial Intelligence
- Computational Chemistry
apis: []
maintainers:
- FN: Kin Lane
email: kin@apievangelist.com
- FN: APIs.json
email: info@apis.io
common:
- type: Website
url: https://www.acelot.com/
- type: Blog
url: https://www.acelot.com/news
- type: BlogRSS
url: https://www.acelot.com/news?format=rss
- type: GitHubOrganization
url: https://github.com/acelot-inc
- type: LinkedIn
url: https://www.linkedin.com/company/acelot-inc./
- type: x-Publications
url: https://www.acelot.com/publications
- type: x-Team
url: https://www.acelot.com/our-team
- type: DomainSecurity
url: security/acelot-inc-domain-security.yml
- type: LLMsTxt
url: llms/acelot-inc-llms.txt
x-enrichment:
date: '2026-09-06'
status: minimal
artifacts_added: 3
pass: local-v3
x-coverage:
state: none
reason: no-developer-program
detail: Acelot is a clinical-stage biopharmaceutical company whose product is a small-molecule therapeutic (ACE-2223), and
its Resolute AI drug-discovery platform is described by the company as employed in-house only — acelot.com is a five-page
Squarespace marketing site with no developer, docs or API section, and every contract-discovery path returned 404 on both
acelot.com and www.acelot.com.
evidence:
- url: https://www.acelot.com/pipeline-and-platform
status: 200
- url: https://www.acelot.com/openapi.json
status: 404
- url: https://www.acelot.com/swagger.json
status: 404
- url: https://www.acelot.com/api-docs
status: 404
- url: https://www.acelot.com/graphql
status: 404
- url: https://www.acelot.com/mcp
status: 404
- url: https://www.acelot.com/llms.txt
status: 404
- url: https://www.acelot.com/.well-known/agent-card.json
status: 404
- url: https://www.acelot.com/.well-known/api-catalog
status: 404
- url: https://github.com/acelot-inc
status: 200
checked: '2026-09-06'
x-legal-name: Acelot, Inc.
Calls without X-API-Key need no key. Calls with it need a paid plan — get a key.
Get an API key
Free tier, no form to fill in. Signing in shares your email address with us — we
store it to create your key and to recognise you if you sign in with another
provider. See our Privacy Policy and
Terms.